JP2010519180A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010519180A5 JP2010519180A5 JP2009546652A JP2009546652A JP2010519180A5 JP 2010519180 A5 JP2010519180 A5 JP 2010519180A5 JP 2009546652 A JP2009546652 A JP 2009546652A JP 2009546652 A JP2009546652 A JP 2009546652A JP 2010519180 A5 JP2010519180 A5 JP 2010519180A5
- Authority
- JP
- Japan
- Prior art keywords
- molecule
- disease
- moshiku
- crohn
- plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000011231 Crohn disease Diseases 0.000 claims 5
- 206010009887 colitis Diseases 0.000 claims 4
- 230000002757 inflammatory effect Effects 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 208000000668 Chronic Pancreatitis Diseases 0.000 claims 3
- 206010009900 Colitis ulcerative Diseases 0.000 claims 3
- 206010033649 Pancreatitis chronic Diseases 0.000 claims 3
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 3
- 238000003745 diagnosis Methods 0.000 claims 3
- 230000028993 immune response Effects 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000002560 therapeutic procedure Methods 0.000 claims 3
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- 108060003951 Immunoglobulin Proteins 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000001124 body fluid Anatomy 0.000 claims 2
- 239000010839 body fluid Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000008105 immune reaction Effects 0.000 claims 2
- 102000018358 immunoglobulin Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 238000007363 ring formation reaction Methods 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 206010008609 Cholangitis sclerosing Diseases 0.000 claims 1
- 208000004232 Enteritis Diseases 0.000 claims 1
- 208000027761 Hepatic autoimmune disease Diseases 0.000 claims 1
- 238000007792 addition Methods 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 208000037976 chronic inflammation Diseases 0.000 claims 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- 150000001945 cysteines Chemical class 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 210000003608 fece Anatomy 0.000 claims 1
- 238000003018 immunoassay Methods 0.000 claims 1
- 238000010166 immunofluorescence Methods 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 208000019423 liver disease Diseases 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 201000000742 primary sclerosing cholangitis Diseases 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 208000010157 sclerosing cholangitis Diseases 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 230000005945 translocation Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE200710004909 DE102007004909A1 (de) | 2007-01-26 | 2007-01-26 | Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Glykoprotein 2(GP2) aus zymogenen Granula des Pankreas zur Differentialdiagnose von entzündlichen Darmerkrankungen und chronischer Pankreatitis |
| EP07090010.5 | 2007-01-26 | ||
| EP07090010A EP1950222A1 (de) | 2007-01-26 | 2007-01-26 | Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Glykoprotein 2 (GP2) aus zymogenen Granula des Pankreas zur Differentialdiagnose von entzündlichen Darmerkrankungen und chronischer Pankreatitis |
| DE102007004909.0 | 2007-01-26 | ||
| PCT/DE2008/000183 WO2008089756A2 (de) | 2007-01-26 | 2008-01-28 | Verfahren zum nachweis von antikörpern aus körperflüssigkeiten durch eine immunreaktion mit glykoprotein 2 (gp2) aus zymogenen granula des pankreas zur differentialdiagnose von entzündlichen darmerkrankungen und chronischer pankreatitis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010519180A JP2010519180A (ja) | 2010-06-03 |
| JP2010519180A5 true JP2010519180A5 (enExample) | 2012-01-12 |
| JP5603083B2 JP5603083B2 (ja) | 2014-10-08 |
Family
ID=39644915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009546652A Active JP5603083B2 (ja) | 2007-01-26 | 2008-01-28 | 炎症性大腸炎及び慢性膵炎の診断のために、膵臓の酵素原顆粒由来の糖タンパク質２（ｇｐ２）との免疫反応を介して体液から抗体を検出する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8058019B2 (enExample) |
| EP (1) | EP2126582B1 (enExample) |
| JP (1) | JP5603083B2 (enExample) |
| KR (1) | KR101283710B1 (enExample) |
| CN (1) | CN101611320B (enExample) |
| AT (1) | ATE515704T1 (enExample) |
| AU (1) | AU2008209176B2 (enExample) |
| CA (1) | CA2674021C (enExample) |
| DK (1) | DK2126582T3 (enExample) |
| ES (1) | ES2369544T3 (enExample) |
| PL (1) | PL2126582T3 (enExample) |
| PT (1) | PT2126582E (enExample) |
| WO (1) | WO2008089756A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7195759B2 (en) * | 2001-06-06 | 2007-03-27 | The University Of Manitoba | Therapeutic uses of glandular kallikrein |
| GB0905076D0 (en) * | 2009-03-24 | 2009-05-06 | Total Scient Ltd | Diagnostic kits and methods |
| WO2011082416A2 (en) * | 2010-01-04 | 2011-07-07 | Mayo Foundation For Medical Education And Research | Peripherin-specific autoantibodies as a marker for neurological and endocrinological disease |
| WO2013173923A1 (en) | 2012-05-25 | 2013-11-28 | Diamedica, Inc. | Formulations of human tissue kallikrein-1 for parenteral delivery and related methods |
| CA2880085C (en) | 2012-06-04 | 2021-09-07 | Diamedica Inc. | Human tissue kallikrein 1 glycosylation isoforms |
| ES2790577T3 (es) | 2014-02-28 | 2020-10-28 | Ga Generic Assays Gmbh | Isoformas de GP2 y su uso en la captura de autoanticuerpos |
| US11340235B2 (en) * | 2014-02-28 | 2022-05-24 | Ga Generic Assays Gmbh | GP2 isoforms and their use in autoantibody capture |
| EP3299818B1 (en) * | 2016-09-26 | 2019-12-04 | GA Generic Assays GmbH | Method for the diagnosis of acute pancreatitis (ap) by detection of glycoprotein 2 isoform alpha (gp2a) |
| EP3523657B1 (en) * | 2016-10-04 | 2023-06-21 | F. Hoffmann-La Roche AG | System and method for identification of a synthetic classifier |
| US11857608B2 (en) | 2017-03-09 | 2024-01-02 | Diamedica Inc. | Dosage forms of tissue kallikrein 1 |
| EP3477300A1 (de) * | 2017-10-25 | 2019-05-01 | Euroimmun Medizinische Labordiagnostika AG | Zellulose-basierter immunadsorber |
| EP4034137A4 (en) * | 2019-09-27 | 2023-09-20 | Duke University | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF PANCREATITIS |
| CN110806485A (zh) * | 2019-11-12 | 2020-02-18 | 广州医科大学附属第二医院 | 一种胶质纤维酸性蛋白抗体检测试剂盒及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5663315A (en) | 1994-12-06 | 1997-09-02 | Alphagene, Inc. | Isolated DNA encoding human GP2 |
| DE19630557C2 (de) * | 1996-07-18 | 1998-07-02 | Schuppan Detlef Priv Doz Dr Dr | Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie |
| US6100098A (en) * | 1997-02-18 | 2000-08-08 | Mcgill University | Anti-AGE IgG and uses thereof for the diagnosis of severe disease |
| US20020082207A1 (en) * | 2000-06-07 | 2002-06-27 | Hirst Shannon K. | Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| JP2004005319A (ja) | 2002-04-24 | 2004-01-08 | Japan Science & Technology Corp | 遺伝子データベース作成方法、遺伝子データベース作成装置、遺伝子データベース作成プログラム、および遺伝子データベース作成プログラムを記録したコンピュータ読み取り可能な記録媒体 |
| US20070275422A1 (en) | 2004-07-26 | 2007-11-29 | The Board Of Trustees Of The Leland Stanford Jr. U | Methods and Compositions for Detecting Pancreatic Disease |
-
2008
- 2008-01-28 PL PL08706848T patent/PL2126582T3/pl unknown
- 2008-01-28 AU AU2008209176A patent/AU2008209176B2/en active Active
- 2008-01-28 CN CN2008800030495A patent/CN101611320B/zh active Active
- 2008-01-28 CA CA2674021A patent/CA2674021C/en active Active
- 2008-01-28 JP JP2009546652A patent/JP5603083B2/ja active Active
- 2008-01-28 WO PCT/DE2008/000183 patent/WO2008089756A2/de not_active Ceased
- 2008-01-28 ES ES08706848T patent/ES2369544T3/es active Active
- 2008-01-28 EP EP08706848A patent/EP2126582B1/de active Active
- 2008-01-28 KR KR1020097014809A patent/KR101283710B1/ko active Active
- 2008-01-28 PT PT08706848T patent/PT2126582E/pt unknown
- 2008-01-28 DK DK08706848.2T patent/DK2126582T3/da active
- 2008-01-28 US US12/523,997 patent/US8058019B2/en active Active
- 2008-01-28 AT AT08706848T patent/ATE515704T1/de active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010519180A5 (enExample) | ||
| US11141460B2 (en) | Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders | |
| KR102724421B1 (ko) | 담즙산 항상성의 조절 및 담즙산 질환 및 질병의 치료 방법 | |
| JP2020073528A (ja) | 肺高血圧症を治療するための組成物および方法 | |
| JP6728352B2 (ja) | 胆汁酸に関係した障害の治療方法 | |
| JP2010229138A5 (enExample) | ||
| NO990190L (no) | Immunologisk fremgangsmÕte for pÕvisning av antistoffer rettet mot vevstransglutaminase (TTG), anvendelse av TTG for diagnostiske formÕl og terapikontroll og oralt farmas°ytisk middel inneholdende TTG | |
| AU2015277438A1 (en) | Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases | |
| JP2006524034A5 (enExample) | ||
| BRPI0614366A2 (pt) | peptìdeo, anticorpo ou fragmento de anticorpo, anticorpo ou ligante funcionalmente equivalente, molécula de ácido nucleico, vetor, célula hospedeira, métodos para expressar um peptìdeo, um anticorpo ou fragmento de anticorpo, um anticorpo ou ligante equivalente e para tratar uma doença em um paciente, composição farmacêutica, composição de vacina, métodos de vacinação de um indivìduo contra uma doença ou um distúrbio e de diagnose de um indivìduo para a presença de anticorpos autoimunes, e, arranjo de peptìdeos | |
| RU2015146419A (ru) | Выделение терапевтических доменов vnar, специфичных по отношению к мишени icosl | |
| JP2013508719A5 (enExample) | ||
| CA2332570A1 (en) | Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine | |
| JP2013178260A5 (enExample) | ||
| JP2010501594A5 (enExample) | ||
| JP2008508861A5 (enExample) | ||
| JP4313433B2 (ja) | イミュノグロブリン結合能を有するペプチド | |
| JP2017523130A5 (enExample) | ||
| ATE297983T1 (de) | Diagnose und behandlung von krankheiten mittels anti-t-zell rezeptor-vbeta-antikörper oder peptide, an denen diese antikörper spezifisch binden, und esrp1 | |
| JP2009529915A5 (enExample) | ||
| JPH02479A (ja) | ｓｎＲＮＰ−Ａ抗原及びそのフラグメント | |
| RU2012100904A (ru) | Биомаркер желудочно-кишечного рака | |
| Dow et al. | Mycobacterium paratuberculosis: A HERV Turn-On for Autoimmunity | |
| US20150335763A1 (en) | Hmgb1-binding beads and uses thereof | |
| WO2018156645A1 (en) | Preventative cancer therapy |